Protective effects of the amino acid glutamine and of ascorbic acid against chromosomal damage induced by doxorubicin in mammalian cells

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 18, Issue 4, 1998, Pages 153-161

  Tavares, Denise Crispim ^a   Cecchi, Andréa O ^a   Antunes, Lusânia M G ^a   Takahashi, Catarina S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antimutagenesis; Ascorbic acid; Chromosomal aberrations; Doxorubicin; Glutamine; Mammalian cells

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; DOXORUBICIN; FREE RADICAL; GLUTAMINE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL PROTECTION; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CROSS LINKING; DNA STRAND BREAKAGE; DRUG EFFECT; DRUG INDUCED DISEASE; GASTROINTESTINAL MUCOSA; GENOTOXICITY; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ASCORBIC ACID; CHO CELLS; CHROMOSOME ABERRATIONS; CRICETINAE; DOXORUBICIN; FEMALE; GLUTAMINE; MALE; RATS; RATS, WISTAR;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA; RATTUS NORVEGICUS;

EID: 0031772639     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1998)18:4<153::AID-TCM1>3.0.CO;2-P     Document Type: Article

References (64)

1. Witzum JL: The oxidative hypothesis of atherosclerosis. Lancet 344:793-795, 1994.
2. Cross CE, van der Vliet A, O'Neill CA, Eisenrich JP: Reactive oxygen species and the lung. Lancet 344:930-932, 1994.
3. Jenner P: Oxidative damage in neurodegenerative disease. Lancet 344:796-798, 1994.
4. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90:7915-7922, 1993.
5. Cerutti PA: Oxy-radicals and cancer. Lancet 344:862-863, 1994.
6. Duthie SJ, Ma A, Ross MA, Collins AR: Antioxidant supplementation decreases oxidative DNA damage in human. Cancer Res 56:1291-1295, 1996.
7. Sun Y: Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 8:583-599, 1990.
8. Chow CK: Vitamin E and oxidative stress. Free Radic Biol Med 11:215-232, 1991.
9. Chen H, Tappel AL: Protection of vitamin E, selenium, trolox C, ascorbic acid, palmitate, acetyl-cysteine, coenzyme Q0, coenzyme Q10, beta-carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo. Free Radic Biol Med 18:949-953, 1995.
10. Kahl R: Synthetic antioxidants: Biochemical actions and interference with radiation, toxic compounds, chemical mutagens and chemical carcinogens. Toxicology 33:185-228, 1984.
11. Sies H: Strategies of antioxidant defense. Eur J Biochem 215:213-219, 1993.
12. Bergström J, Fuerst P, Noree LO, Viunars E: Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol 36:693-696, 1974.
13. Salloum RM, Souba WW, Klimberg VS, Plumley DA, Dolson DJ, Bland KI, Copeland EM: Glutamine is superior to glutamate in supporting gut metabolism, stimulating intestinal glutaminase activity and preventing bacterial translocation. Surg Forum 40:6-8, 1989.
14. Jacobs DO, Evans DA, O'Dwyer ST, Smith RJ, Wilmore DW: Disparate effects of 5-fluorouracil on the ileum and colon of enterally fed rats with protection by dietary glutamine. Surg Forum 38:45-47, 1987.
15. O'Dwyer ST, Scott T, Smith RJ: 5-Fluorouracil toxicity on small intestinal mucosa but not white blood cells is decreased by glutamine (abstract). Clin Res 35:369, 1987.
16. Fox AD, Kripke JA, De Paula JA, Berman JM, Settle RG, Rombeau JL: Effect of glutamine-supplemented enterai diet on methotrexate-induced enterocolitis. J Parent Enteral Nutr 12:325-331, 1988.
17. Muscaritoli M, Micozzi A, Conversano L, Martino P, Petti MC, Cartoni C, Cascino A, Rossi-Fanelli F: Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity. Eur J Cancer 33:319-320, 1997.
18. Klimberg VS, Salloum RM, Kasper M, Plumley DA, Dolson DJ, Hautamaki RD, Mendenhall WR: Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg 125:1040-1045, 1990.
19. Klimberg VS, Souba WW, Dolson DJ, Salloum RM, Hautamaki RD, Plumley DA, Mendenhall WM: Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer 66:62-68, 1990.
20. Souba WW, Klimberg VS, Copeland EM: Glutamine nutrition in the management of radiation enteritis. J Parent Enterai Nutr 14(Suppl):106S-108S, 1990.
21. Campos FG, Mucerino DR, Waitzberg DL, Logulo AF, Ibrahm RE, Nadalin W, Haber-Gama A: Efeitos protetores da glutamina e dieta elementar na enterocolite actínica aguda: avaliação histológica. Rev Ass Med Brasil 40:143-149, 1994.
22. Campos FG, Waitzberg DL, Mucerino DR, Gonçalves EL, Logulo AF, Haber-Gama A, Rombeau JL: Protective effects of glutamine enriched diets on acute actinic enteritis. Nutr Hosp 11:167-177, 1996.
23. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, Morrow FD, Jacobs DO, Smith RJ, Antin JH, Wilmore DW: Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation: A randomized, double-blind, controlled study. Ann Intern Med 116:821-828, 1992.
24. Schloerb PR, Amare M: Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications: A randomized, double-blind study. J Parent Enterai Nutr 17:407-413, 1993.
25. Kaibara A, Yoshida S, Yamasaki K, Ishibashi N, Kakegawa T: Effect of glutamine and chemotherapy on protein metabolism in tumor-bearing rats. J Surg Res 57:143-149, 1994.
26. Skubitz KM, Anderson PM: Oral glutamine to prevent chemotherapy induced stomatitis: A pilot study. J Lab Clin Med 127:223-228, 1996.
27. van der Hulst RRWJ, von Meyenfeldt MF, Deutz NEP, Soeters PB: Glutamine extraction by the gut is reduced in patients with depleted gastrointestinal cancer. Ann Surg 225:112-121, 1997.
28. Cameron E, Pauling L: Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 75:4538-4542, 1978.
29. Bin DF: Update on the effects of vitamins A, C, and E and selenium on carcinogenesis. Proc Soc Exp Biol Med 183:311-320, 1986.
30. Lupulescu A: The role of vitamins A, β-carotene, E and C in cancer cell biology. Int J Vit Nutr Res 63:3-14, 1993.
31. Harakeh S, Jariwalla RJ, Pauling L: Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl Acad Sci USA 87:7245-7249, 1990.
32. Niki E: Vitamin C as an antioxidant. World Rev Nutr Diet 64:1-30, 1990.
33. Shamberger RJ: Genetic toxicology of ascorbic acid. Mutat Res 133:135-159, 1984.
34. Gulati DK, Witt K, Anderson B, Zeiger E, Shelby MD: Chromosome aberration and sister-chromatid exchange tests in Chinese hamster ovary cells in vitro. III. Results with 27 chemicals. Environ Mol Mutagen 13:133-193, 1989.
35. Singh NP: Sodium ascorbate induces DNA single-strand breaks in human cells in vitro. Mutat Res 375:195-203, 1997.
36. Bodley A, Liu LF, Israel M, Seshadri R, Koseki Y, Giuliani FC, Kirschenbaum S, Silber R, Potmesil M: DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Cancer Res 49:5969-5978, 1989.
37. Faure H, Coudray C, Mousseau M, Ducros V, Douki T, Bianchini F, Cadet J, Favier A: 5-Hydroxymethyluracil excretion, plasma t-bars and plasma antioxidant vitamins in adriamycin-treated patients. Free Radic Med Biol 20:979-983, 1996.
38. Ford CE, Hamerton JL: A colchicine hypotonic citrate squash sequence for mammalian chromosomes. Stain Tech 3:247-251, 1956.
39. Moorhead PS, Nowell PC, Mellman WL, Battipps DM, Hungerford DA: Chromosome preparation of leukocytes cultured from human peripheral blood. Exp Cell Res 20:613-616, 1960.
40. Stewart DJ, Evans WK, Shepherd FA, Wilson KS, Pritchard KI, Trudeau ME, Wilson JJ, Martz K: Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: Superiority of doxorubicin. J Clin Oncol 15:1897-1905, 1997.
41. Keizer HG, Pinedo HM, Schuurhuis GJ, Joenje H: Doxorubicin (Adriamycin): A critical review of free radical-dependent mechanism of cytotoxicity. Pharmacol Ther 47:219-231, 1990.
42. Blijham GH: Prevention and treatment of organ toxicity during high-dose chemotherapy: An overview. Anti-Cancer Drugs 4:527-533, 1993.
43. Cozzi R, Ricordy R, Aglitti T, Gatta V, Perticone P, De Salvia R: Ascorbic acid and β-carotene as modulators of oxidative damage. Carcinogenesis 18:223-228, 1997.
44. Rosenberg LJ, Hittelman WN: Direct and indirect clastogenic activity of anthracenedione in Chinese hamster ovary cells. Cancer Res 43:3270-3275, 1983.
45. Newsholme EA, Newsholme P, Curi R, Challouner E, Ardawi MSM: A role for muscle in the immune system and its importance in surgery, trauma sepsis and burns. Nutrition 4:261-268, 1988.
46. Yoshida S, Yunoki T, Aoyagy K, Ohta J, Ishibashi N, Noake T, Kalegawa T: Effect of glutamine supplement and hepatectomy on DNA and protein synthesis in the remnant liver. J Surg Res 59:475-481, 1995.
47. Hong RW, Rounds JD, Helton WS, Robinson MK, Wilmore DW: Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 215:114-119, 1992.
48. Wilmore DW: Metabolic support of the gastrointestinal tract. Potential gut protection during intensive cytotoxic therapy. Cancer 79:1794-1803, 1997.
49. Winters R, Mattheus R, Ercal N, Krishnan K: Glutamine protects Chinese hamster ovary cells from radiation killing. Life Sci 55:713-720, 1994.
50. Anderson D, Francis AJ: The modulating effects of antioxidants in rat embryos and Sertoli cells in culture. In Bronzetti G, et al.: "Antimutagenesis and Anticarcinogenesis Mechanisms III." New York: 1993, pp 189-200.
51. Gebhart E, Wagner H, Grziwok K, Behnsen H: The action of anticlastogens in human lymphocyte culture and their modification by rat-liver S9 mix, II. Studies with vitamins C and E. Mutat Res 149:83-94, 1985.
52. Aidoo A, Lyn-Cook LE, Lensing S, Warner W: Ascorbic acid (vitamin C) modulates the mutagenic effects produced by an alkylating agent in vivo. Environ Mol Mutagen 24:220-228, 1994.
53. Sato K, Niki E, Shimasaki H: Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys 279:402-405, 1990.
54. Anderson D: Antioxidant defences against reactive oxygen species causing genetic and other damage. Mutat Res 350:103-108, 1996.
55. Ohta T, Watanabe K, Moriya M, Shirasu Y, Kada T: Antimutagenic effects of cinnamaldehyde on chemical mutagenesis in Escherichia coli. Mutat Res 107:219-227, 1983.
56. Anderson D, Basaran N, Blowers SD, Edwards AJ: The effect of antioxidants on bleomycin treatment in in vitro and in vivo genotoxicity assays. Mutat Res 329:37-47, 1995.
57. Meneghini R: Genotoxicity of active oxygen species in mammalian cells. Mutat Res 195:215-230, 1988.
58. Stich HF, Karin J, Koropatnick J, Lo L: Mutagenic action of ascorbic acid. Nature 260:122-124, 1976.
59. Stich HF, Wei L, Whiting RF: The enhancing effect of transition metals on the chromosome-damaging action of ascorbate. Cancer Res 39:4145-4151. 1979.
60. Renner HW: In vivo effects of single or combined dietary antimutagens on mutagen-induced chromosomal aberrations. Mutat Res 244:185-188, 1990.
61. Gebhart E: The anticlastogenic effect of various combinations of cysteamine, AET, HCT, and amino acids on chromosome damage by trenimon and bleomycin in human lymphocytes in vitro. Hum Genet 43:185-203, 1978.
62. Sies H, Stahl W: Vitamins E and C. β-carotene and other carotenoids as antioxidants. Am J Clin Nutr 62(Suppl):1315S-1321S, 1995.
63. Niki E, Nogushi N, Tsuchihashi H, Gotoh N: Interaction among vitamin C, vitamin E, and β-carotene. Am J Clin Nutr 62(Suppl):1322S-1326S.
64. Jacob RA: The integrated antioxidant system. Nutr Res 15:755-766, 1995.